Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure
PharmaShots
APRIL 25, 2023
Founded Year: 2007 Total Employees: ~100 Headquarters: Pennsylvania, United States Market Cap: $477.1M Through its internal development, partnerships, and acquisitions, the company has put together four technology platforms that primarily focus on antibodies, T cells, innate immunity, and siRNAs. R&D Expenditure: $84.4M
Let's personalize your content